Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist
Journal Title: The AAPS Journal - Year 2004, Vol 6, Issue 1
Abstract
The purpose of this study was to assess whether male rats whose testosterone levels were suppressed to castration levels (<0.5 ng/mL) for a 1-year period by the sustained delivery of orntide acetate, a GnRH antagonist, would return to fertility (ie, produce offspring) after serum testosterone returned to control levels. Male rats comprising a treatment group (orntide microspheres, dose=27 mg/kg/y), a vehicle control group, and a control group of proven male breeders were used. For the treatment and vehicle control groups, serum orntide and testosterone levels were monitored at periodic intervals for 14 months from the initiation of treatment. After serum testosterone levels returned to vehicle control levels and orntide serum levels were no longer discernible for the treated group, each of the animals was housed with 2 drug-naive, female, proven breeders. All the breeder females produced offspring with the exception of 1 female housed with a male rat from the treatment group and the 2 females housed with a single male rat from the vehicle control group. The mean size and weight of the litters from each group were not statistically different. Further, fertility of the offspring from each group was assessed. The male and female offspring studied were all shown to be fertile. The results suggest that lack of fertility due to testosterone suppression in male rats is reversible after cessation of treatment with the GnRH analog, orntide.
Authors and Affiliations
Susan S. D'Souza, Francesca Selmin, Santos B Murty, Wei Qiu, BC Thanoo, Patrick P DeLuca
Keywords
Related Articles
- EP ID EP681956
- DOI 10.1208/ps060110
- Views 92
- Downloads 0
Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical Platform
Decisions about efficacy and safety of therapeutic proteins (TP) designed to target soluble ligands are made in part by their ex vivo quantification. Ligand binding assays (LBAs) are critical tools in measuring serum TP...
Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics
published July 14, 2000
Peptide Developability at the Discovery-to-Development Interface—Current State and Future Opportunities
Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions
In vitro-in vivo correlations (IVIVCs) play an important role in formulation development and drug approval. At the heart of IVIVC is deconvolution, the method of deriving an in vivo “dissolution profile”...
Scientific and Regulatory Standards for Assessing Product Performance Using the Similarity Factor, f2
The similarity factor, f2, measures the sameness of dissolution profiles. The following commentary is an overview of discussions and presentations from a group of industry and US regulatory experts that have integrated t...